1. Traish, AM, Haider, A, Haider, KS, Doros, G, Saad, F. Long-term testosterone therapy improves cardiometabolic function and reduces risk of cardiovascular disease in men with hypogonadism. J Cardiovasc Pharmacol Ther. 2017;22(5):414–433. doi:10.1177/1074248417691136
Google Scholar | SAGE Journals | ISI2. Kloner, RA, Carson, C, Dobs, A, Kopecky, S, Mohler, ER. Testosterone and cardiovascular disease. J Am Coll Cardiol. 2016;67(5):545–557. doi:10.1016/j.jacc.2015.12.005
Google Scholar | Crossref | Medline | ISI3. Ridker, PM, Silvertown, JD. Inflammation, C-reactive protein, and atherothrombosis. J Periodontol. 2008;79(8s):1544–1551. doi:10.1902/jop.2008.080249
Google Scholar | Crossref | Medline4. Atallah, A, Mhaouty-Kodja, S, Grange-Messent, V. Chronic depletion of gonadal testosterone leads to blood–brain barrier dysfunction and inflammation in male mice. J Cereb Blood Flow Metab. 2017;37(9):3161–3175. doi:10.1177/0271678X16683961
Google Scholar | SAGE Journals | ISI5. Libby, P . Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(9):2045–2051. doi:10.1161/ATVBAHA.108.179705
Google Scholar | Crossref | Medline | ISI6. Kataoka, T, Hotta, Y, Maeda, Y, Kimura, K. Testosterone deficiency causes endothelial dysfunction via elevation of asymmetric dimethylarginine and oxidative stress in castrated rats. J Sex Med. 2017;14(12):1540–1548. doi:10.1016/j.jsxm.2017.11.001
Google Scholar | Crossref | Medline7. Srinath, R, Gottesman, RF, Hill Golden, S, Carson, KA, Dobs, A. Association between endogenous testosterone and cerebrovascular disease in the ARIC study (Atherosclerosis Risk in Communities). Stroke. 2016;47(11):2682–2688. doi:10.1161/STROKEAHA.116.014088
Google Scholar | Crossref | Medline8. Onasanya, O, Iyer, G, Lucas, E, Lin, D, Singh, S, Alexander, GC. Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews. Lancet Diabetes Endocrinol. 2016;4(11):943–956. doi:10.1016/S2213-8587(16)30215-7
Google Scholar | Crossref | Medline9. Choi, KM, Han, K, Park, S, et al. Implication of liver enzymes on incident cardiovascular diseases and mortality: a nationwide population-based cohort study. Sci Rep. 2018;8(1):3764. doi:10.1038/s41598-018-19700-8
Google Scholar | Crossref | Medline10. Yilmaz, Y, Kurt, R, Yonal, O, et al. Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis. Atherosclerosis. 2010;211(1):182–186. doi:10.1016/j.atherosclerosis.2010.01.049
Google Scholar | Crossref | Medline11. Tsilidis, KK, Rohrmann, S, McGlynn, KA, et al. Association between endogenous sex steroid hormones and inflammatory biomarkers in US men. Andrology. 2013;1(6):919–928. doi:10.1111/j.2047-2927.2013.00129.x
Google Scholar | Crossref | Medline12. Schooling CM . Androgen activity and markers of inflammation among men in NHANES III. Am J Hum Biol. 2013;25(5):622–628. doi:10.1002/ajhb.22421
Google Scholar | Crossref | Medline13. Centers for Disease Control and Prevention . MEC Laboratory Procedures Manual. Published 2016. Accessed February 23, 2020. https://www.cdc.gov/nchs/data/nhanes/nhanes_15_16/2016_MEC_Laboratory_Procedures_Manual.pdf
Google Scholar14. Centers for Disease Control and Prevention . Laboratory Procedure Manual—Total Estradiol and Total Testosterone. Updated November 2018. Accessed February 23, 2020. https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/labmethods/TST_I_MET_TST_EST.pdf
Google Scholar15. Centers for Disease Control and Prevention . Laboratory Procedure Manual—High Sensitivity C-Reactive Protein (HS-CRP). Updated May 2019. Accessed February 23, 2020. https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/labmethods/HSCRP_I_MET.pdf
Google Scholar16. Centers for Disease Control and Prevention . Laboratory Procedure Manual—Aspartate Aminotransferase (AST). Updated September 2017. Accessed February 23, 2020. https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/labmethods/BIOPRO_I_MET_AST_DXC800and660i.pdf
Google Scholar17. Centers for Disease Control and Prevention . Laboratory Procedure Manual—Alanine Amino Transferase (ALT). Updated September 2017. Accessed February 23, 2020. https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/labmethods/BIOPRO_I_MET_ALT_DXC800and660i.pdf
Google Scholar18. Bhasin, S, Pencina, M, Jasuja, GK, et al. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham heart study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab. 2011;96(8):2430–2439. doi:10.1210/jc.2010-3012
Google Scholar | Crossref | Medline19. Hukkanen, J, Jacob, P, Benowitz, NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev. 2005;57(1):79–115. doi:10.1124/pr.57.1.3
Google Scholar | Crossref | Medline | ISI20. National Institutes of Health . High Blood Cholesterol: What You Need to Know. National Heart, Lung, and Blood Institute. Published 2005. Accessed March 9, 2020. http://www.nhlbi.nih.gov/health/resources/heart/heart-cholesterol-hbc-what-html
Google Scholar21. Arvind, R., Murali, WDC. Liver test interpretation—approach to the patient with liver disease: a guide to commonly used liver tests. Dis Manag. 2017;1(7446):983. doi:10.1016/B978-1-4377-1604-7.00148-2
Google Scholar22. Haider, KS, Haider, A, Doros, G, Traish, A. Long-term testosterone therapy improves urinary and sexual function, and quality of life in men with hypogonadism: results from a propensity matched subgroup of a controlled registry study. J Urol. 2018;199(1):257–265. doi:10.1016/j.juro.2017.07.039
Google Scholar | Crossref | Medline23. Kelly, DM, Nettleship, JE, Akhtar, S, et al. Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient mice. Life Sci. 2014;109(2):95–103. doi:10.1016/j.lfs.2014.06.007
Google Scholar | Crossref | Medline24. Kim, S, Kwon, H, Park, JH, et al. A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease. BMC Gastroenterol. 2012;12(1):69. doi:10.1186/1471-230X-12-69
Google Scholar | Crossref | Medline25. Mody, A, White, D, Kanwal, F, Garcia, JM. Relevance of low testosterone to nonalcoholic fatty liver disease. Cardiovasc Endocrinol. 2015;4(3):83–89. doi:10.1097/XCE.0000000000000057
Google Scholar | Crossref | Medline26. Bujanda, L, Hijona, E, Hijona, L, Arenas, JI. Inflammatory mediators of hepatic steatosis. Mediators Inflamm. 2010;2010:1–7. doi:10.1155/2010/837419
Google Scholar27. Newsome, PN, Cramb, R, Davison, SM, et al. Guidelines on the management of abnormal liver blood tests. Gut. 2018;67(1):6–19. doi:10.1136/gutjnl-2017-314924
Google Scholar | Crossref | Medline28. Traish, A, Bolanos, J, Nair, S, Saad, F, Morgentaler, A. Do androgens modulate the pathophysiological pathways of inflammation? Appraising the contemporary evidence. J Clin Med. 2018;7(12):549. doi:10.3390/jcm7120549
Google Scholar | Crossref29. Bisoendial, RJ, Boekholdt, SM, Vergeer, M, Stroes, ESG, Kastelein, JJP. C-reactive protein is a mediator of cardiovascular disease. Eur Heart J. 2010;31(17):2087–2095. doi:10.1093/eurheartj/ehq238
Google Scholar | Crossref | Medline | ISI30. Kuo, TM, Yeh, KT, Hsu, HT, et al. ALPK1 affects testosterone mediated regulation of proinflammatory cytokines production. J Steroid Biochem Mol Biol. 2015;154:150–158. doi:10.1016/j.jsbmb.2015.08.007
Google Scholar | Crossref | Medline31. Son, BK, Kojima, T, Ogawa, S, Akishita, M. Testosterone inhibits aneurysm formation and vascular inflammation in male mice. J Endocrinol. 2019;241(3):307–317. doi:10.1530/JOE-18-0646
Google Scholar | Crossref | Medline32. Vignozzi, L, Morelli, A, Filippi, S, et al. Farnesoid X receptor activation improves erectile function in animal models of metabolic syndrome and diabetes. J Sex Med. 2011;8(1):57–77. doi:10.1111/j.1743-6109.2010.02073.x
Google Scholar | Crossref | Medline33. Boden, WE, Miller, MG, McBride, R, et al. Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease. Am Heart J. 2020;224:65–76. doi:10.1016/j.ahj.2020.03.016
Google Scholar | Crossref | Medline34. Kapoor, D, Jones, TH. Androgen deficiency as a predictor of metabolic syndrome in aging men: an opportunity for intervention? Drugs Aging. 2008;25(5):357–369.
Google Scholar | Crossref | Medline35. Stout, M, Tew, GA, Doll, H, et al. Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study. Am Heart J. 2012;164(6):893–901. doi:10.1016/j.ahj.2012.09.016
Google Scholar | Crossref | Medline36. Zhang, X, Huang, K, Saad, F, Haider, KS, Haider, A, Xu, X. Testosterone therapy reduces cardiovascular risk among hypogonadal men: a prospective cohort study in Germany. Androg Clin Res Ther. 2021;2(1):64–72. doi:10.1089/andro.2020.0015
Google Scholar | Crossref